Late-gadolinium enhancement on CMR is associated with adverse clinical outcomes and determines remodelling in heart failure patients treated with sacubitril/valsartan: a retrospective study

29 June 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: ePoster session Ventricular Remodelling HFA Premium Access Heart Failure 2021

ESC 365 is supported by

ESC 365 is supported by